ScholarIQanswers from OpenAlex

Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease

PaperCitations, authors & open-access status

Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease have?

ScholarIQcitation count

Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease has 387 citations in the OpenAlex counts ScholarIQ stores.

When was Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease published?

ScholarIQyear

Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease has 2004 year in the ScholarIQ index.

What is the open-access status of Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease?

ScholarIQoa status

Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease has closed oa status in the ScholarIQ index.

What is the DOI of Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease?

ScholarIQdoi

The DOI for Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease is on the source record.

What is the PMID of Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease?

ScholarIQpmid

The PMID for Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease is on the source record.

What is the OpenAlex record for Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease?

ScholarIQopenalex

The OpenAlex for Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial